|
Name |
3,3''-dihydroxy-6'-O-desmethylterphenyllin
|
Molecular Formula | C19H16O7 | |
IUPAC Name* |
2,5-bis(3,4-dihydroxyphenyl)-4-methoxybenzene-1,3-diol
|
|
SMILES |
COC1=C(C(=C(C=C1C2=CC(=C(C=C2)O)O)O)C3=CC(=C(C=C3)O)O)O
|
|
InChI |
InChI=1S/C19H16O7/c1-26-19-11(9-2-4-12(20)14(22)6-9)8-16(24)17(18(19)25)10-3-5-13(21)15(23)7-10/h2-8,20-25H,1H3
|
|
InChIKey |
VKBPMLDNIWHWKC-UHFFFAOYSA-N
|
|
Synonyms |
3,3''-dihydroxy-6'-O-desmethylterphenyllin; CHEMBL465798; CHEBI:67401; BDBM50347541; 3,3''-Dihydroxy-5'-O-desmethylterphenyllin; Q27135863; 2,5-bis(3,4-dihydroxyphenyl)-4-methoxybenzene-1,3-diol; 3'-Methoxy-1,1':4',1''-terphenyl-2',3,3'',4,4'',6'-hexol
|
|
CAS | NA | |
PubChem CID | 10316213 | |
ChEMBL ID | CHEMBL465798 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 356.3 | ALogp: | 3.0 |
HBD: | 6 | HBA: | 7 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 131.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 26 | QED Weighted: | 0.391 |
Caco-2 Permeability: | -5.635 | MDCK Permeability: | 0.00000706 |
Pgp-inhibitor: | 0.013 | Pgp-substrate: | 0.013 |
Human Intestinal Absorption (HIA): | 0.038 | 20% Bioavailability (F20%): | 0.972 |
30% Bioavailability (F30%): | 0.997 |
Blood-Brain-Barrier Penetration (BBB): | 0.005 | Plasma Protein Binding (PPB): | 97.32% |
Volume Distribution (VD): | 0.489 | Fu: | 3.10% |
CYP1A2-inhibitor: | 0.88 | CYP1A2-substrate: | 0.362 |
CYP2C19-inhibitor: | 0.092 | CYP2C19-substrate: | 0.043 |
CYP2C9-inhibitor: | 0.603 | CYP2C9-substrate: | 0.548 |
CYP2D6-inhibitor: | 0.109 | CYP2D6-substrate: | 0.516 |
CYP3A4-inhibitor: | 0.155 | CYP3A4-substrate: | 0.108 |
Clearance (CL): | 14.135 | Half-life (T1/2): | 0.871 |
hERG Blockers: | 0.247 | Human Hepatotoxicity (H-HT): | 0.056 |
Drug-inuced Liver Injury (DILI): | 0.948 | AMES Toxicity: | 0.666 |
Rat Oral Acute Toxicity: | 0.094 | Maximum Recommended Daily Dose: | 0.103 |
Skin Sensitization: | 0.949 | Carcinogencity: | 0.052 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.934 |
Respiratory Toxicity: | 0.073 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005040 | 0.813 | D0K8KX | 0.440 | ||||
ENC002756 | 0.750 | D04AIT | 0.402 | ||||
ENC002758 | 0.608 | D0U3YB | 0.394 | ||||
ENC005039 | 0.607 | D0AZ8C | 0.331 | ||||
ENC005391 | 0.607 | D06GCK | 0.321 | ||||
ENC002755 | 0.551 | D07MGA | 0.320 | ||||
ENC002759 | 0.549 | D0KN2M | 0.293 | ||||
ENC002757 | 0.549 | D08LFZ | 0.290 | ||||
ENC002471 | 0.521 | D0J7RK | 0.279 | ||||
ENC002475 | 0.469 | D00KRE | 0.272 |